Thermo Fisher Scientific will be at CPHI Barcelona, October 24-26. Find us at booth #3K50 or schedule a meeting today.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
mRNA is being explored as a therapeutic strategy for a variety of clinical applications, including infectious disease, protein replacement, and immuno-oncology, among others.
But despite its inherent advantages, several challenges still exist, including:
- Optimizing mRNA stability and protein expression
- Developing production and purification processes
- Designing an efficient therapeutic delivery vehicle
- Balancing the innate immune system response
- Obtaining the intended therapeutic response
Our interactive article explores each industry challenge in detail and examines avenues to overcome them.